UroGen Pharma Ltd Strategic Asset Allocation Index
UroGen Pharma Ltd strategic asset allocation index. UroGen Pharma Ltd (URGN) has a Strategic Asset Allocation Index of 18.2% as of September 2024. Strategic assets (PP&E of $- plus long-term investments of $4.64 Million) total $4.64 Million, measured against net assets of $25.52 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See URGN equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of UroGen Pharma Ltd (2013–2021)
Strategic asset allocation index of UroGen Pharma Ltd from 2013 to 2021. This chart shows how UroGen Pharma Ltd's Strategic Asset Allocation Index has evolved across 9 annual periods from 2013 to 2021. As of September 2024, the index stands at 18.2%, representing strategic assets of $4.64 Million against net assets of $25.52 Million USD. Check UroGen Pharma Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
UroGen Pharma Ltd Strategic Asset Allocation Index by Year (2013–2021)
UroGen Pharma Ltd strategic asset allocation index by year from 2013 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for UroGen Pharma Ltd from 2013 to 2021, covering 9 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see UroGen Pharma Ltd (URGN) total market value.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 31.4% | $2.64 Million | $1.97 Million | $675.00K | $8.41 Million | ▲ +25.1 pp |
| 2020 | 6.3% | $6.10 Million | $4.20 Million | $1.89 Million | $96.36 Million | ▼ -23.2 pp |
| 2019 | 29.5% | $53.27 Million | $4.71 Million | $48.55 Million | $180.30 Million | ▲ +28.5 pp |
| 2018 | 1.1% | $948.00K | $948.00K | $- | $90.09 Million | ▼ -0.1 pp |
| 2017 | 1.2% | $805.00K | $805.00K | $- | $68.52 Million | ▼ -3.4 pp |
| 2016 | 4.5% | $741.00K | $741.00K | $- | $16.31 Million | ▲ +3.0 pp |
| 2015 | 1.5% | $259.00K | $259.00K | $- | $17.15 Million | ▼ -0.5 pp |
| 2014 | 2.0% | $71.00K | $71.00K | $- | $3.47 Million | ▼ -0.8 pp |
| 2013 | 2.8% | $77.00K | $77.00K | $- | $2.74 Million | — |